The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment

NCT07069842 · clinicaltrials.gov ↗

RECRUITING

Status

170

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Immunotherapy

Interventions

DIAGNOSTIC_TEST: Multiplex Immunofluorescence Technology
DIAGNOSTIC_TEST: Co-Immunoprecipitation (Co-IP) Technology
DIAGNOSTIC_TEST: Immunohistochemistry
DIAGNOSTIC_TEST: In situ hybridization with chromogenic detection

Sponsor

Changzhi People's Hospital Affiliated to Changzhi Medical College